Healthcare Solutions
-
Wilson receives National Science Foundation CAREER Award
John T. Wilson, assistant professor of chemical and biomolecular engineering, has received an NSF Faculty Early Career Development award. The five-year, $500,000 grant will allow him to develop new synthetic materials for “encoding” immunological messages and tightly regulating their delivery to the organs, cells and pathways of the immune system. Read MoreApr 4, 2016
-
Biomedical engineering undergrads retrofit toy car for toddler’s special needs
Undergraduates taking Amanda Lowery’s Material Manipulations course have redesigned a toy car so a two-year-old with cerebral palsy can drive it. Read MoreApr 4, 2016
-
Deep brain stimulation program marks milestones
Vanderbilt Clinical Neurosciences is marking two milestones — the 20th anniversary of its deep brain stimulation (DBS) program and its 1,000th DBS procedure. Read MoreMar 24, 2016
-
New treatment for Crohn’s disease
A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease. Read MoreMar 22, 2016
-
Monroe Carell Jr. Children’s Hospital at Vanderbilt and Ryan Seacrest Foundation Open Seacrest Studios, a New Multimedia Broadcast Studio
Taylor Swift Surprises Patients for the First Broadcast with Seacrest Monroe Carell Jr. Children’s Hospital at Vanderbilt, in partnership with the Ryan Seacrest Foundation (RSF), today celebrated the opening of a new state-of-the-art, multimedia broadcast studio, named Seacrest Studios, inside Children’s Hospital. The launch… Read MoreMar 18, 2016
-
Study suggests cancer’s ‘clock’ can be rewound
Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented. Read MoreMar 17, 2016
-
Life-changing impact of cornea transplantation celebrated
Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March. Read MoreMar 17, 2016
-
Study explores carb-loading’s effect on heart
Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found. Read MoreMar 17, 2016
-
FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use
The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States. Read MoreMar 10, 2016
-
Vanderbilt researchers identify potential antibody treatment for H7 avian flu
Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat. Read MoreMar 7, 2016
-
First VICC cancer patient treated with new immunotherapy
For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. Read MoreMar 3, 2016
-
Study seeks to ease pediatric HIV infection rates in Africa
Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce. Read MoreMar 3, 2016
-
Compassion key to VUMC’s strategic mission: Balser
“Service through compassion” was the theme of the Winter 2016 Clinical Enterprise Leadership Assembly at Vanderbilt University Medical Center (VUMC). Read MoreFeb 18, 2016
-
Study explores less invasive way to monitor colorectal cancer
Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States. Read MoreFeb 18, 2016
-
Liver transplant program celebrates 25 years of care
Twenty-five years ago, Julie Damon’s family was preparing to say their goodbyes. Comatose and on life support at Vanderbilt University Medical Center (VUMC) with liver failure, the options for the 45-year-old wife and mother of two were slipping away. Read MoreFeb 18, 2016
-
Study leads to new heart transplant decision support tool
Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant. Read MoreFeb 18, 2016
-
VU Inside: Dr. William Fissell’s Artificial Kidney
Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William Fissell IV is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an artificial implantable kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart. Read MoreFeb 12, 2016
-
Cardiologist Hood keeps patients’ best interests at heart
When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist. Read MoreFeb 11, 2016
-
Transplant Center initiative seeks to boost cancer education
Lindsay Ramsey Smith, MSN, R.N., a quality consultant for the Vanderbilt Transplant Center (VTC), recently uncovered some interesting data that sparked a center-wide improvement project. Read MoreFeb 11, 2016
-
Slight chemical change may improve TB treatments: study
One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered. Read MoreFeb 11, 2016